Purdue University continued its run of strong research funding and partnerships during fiscal year 2025, with the ...

Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...

Deep-pocketed investors have adopted a bullish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Eli Lilly on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use, which previously recommended against approval of Kisunla, is now backing the drug for use ...

Key Points Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral GLP-1 candidate will soon report key phase 3 results in ...

Eli Lilly and Company (NYSE:LLY) is a research-driven pharmaceutical leader headquartered in Indiana.

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.

Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy Gilmore 2” star.

Former Purdue women's basketball standout Abbey Ellis won gold with Australia in this summer's FIBA Women's Asia Cup. She played at Purdue from 2021-24.